{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:09:32Z","timestamp":1789693772370,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jaci.2023.08.024","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T11:15:21Z","timestamp":1693566921000},"page":"1460-1469.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Dupilumab strengthens herpes simplex virus type 1\u2013specific immune responses in atopic dermatitis"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4806-599X","authenticated-orcid":false,"given":"Stephan","family":"Traidl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Harries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kienlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Begemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart M.","family":"Roesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Werfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10247","key":"10.1016\/j.jaci.2023.08.024_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2023.08.024_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/all.15486","article-title":"Single-cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis","volume":"78","author":"Zhang","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2023.08.024_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/164_2021_492","article-title":"Atopic eczema: pathophysiological findings as the beginning of a new era of therapeutic options","volume":"268","author":"Traidl","year":"2022","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jaci.2023.08.024_bib4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/bjd.20887","article-title":"Risk of herpesvirus, serious and opportunistic infections in atopic dermatitis: a population-based cohort study","volume":"186","author":"Wan","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.08.024_bib5","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/jdv.16090","article-title":"Recurrent eczema herpeticum\u2014a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients","volume":"34","author":"Seegr\u00e4ber","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.08.024_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaci.2009.05.020","article-title":"Phenotype of atopic dermatitis subjects with a history of eczema herpeticum","volume":"124","author":"Beck","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.08.024_bib7","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1111\/all.14853","article-title":"Eczema herpeticum in atopic dermatitis","volume":"76","author":"Traidl","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2023.08.024_bib8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaci.2014.07.018","article-title":"Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum","volume":"134","author":"Bin","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.08.024_bib9","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/bjd.12382","article-title":"Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon-\u03b3\u2013producing CD8+ T cells","volume":"169","author":"Mathias","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3 pt 1","key":"10.1016\/j.jaci.2023.08.024_bib10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jid.2011.374","article-title":"Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum","volume":"132","author":"Gao","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.08.024_bib11","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jaci.2015.06.047","article-title":"Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum","volume":"136","author":"Gao","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.08.024_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13148-019-0714-1","article-title":"Replicated methylation changes associated with eczema herpeticum and allergic response","volume":"11","author":"Boorgula","year":"2019","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jaci.2023.08.024_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","article-title":"Cellular and molecular immunologic mechanisms in patients with atopic dermatitis","volume":"138","author":"Werfel","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.08.024_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/S0190-9622(03)00896-X","article-title":"Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases","volume":"49","author":"Wollenberg","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.08.024_bib15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.jid.5700657","article-title":"Risk factors of atopic dermatitis patients for eczema herpeticum","volume":"127","author":"Peng","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.08.024_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/all.13986","article-title":"IgE reactivity against herpes simplex virus 1 in patients with atopic dermatitis complicated by eczema herpeticum","volume":"75","author":"Cabanillas","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2023.08.024_bib17","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/exd.14327","article-title":"Herpes simplex virus 1 proteins can induce skin inflammation in an atopic dermatitis-like mouse model","volume":"30","author":"Novak","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2023.08.024_bib18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaci.2017.09.048","article-title":"Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus\u2013specific type 2 immune responses","volume":"141","author":"Traidl","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.08.024_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaad.2017.09.052","article-title":"Risk of infection in patients with atopic dermatitis treated with dupilumab: a meta-analysis of randomized controlled trials","volume":"78","author":"Fleming","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.08.024_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40257-019-00445-7","article-title":"Infections in dupilumab clinical trials in atopic dermatitis: a comprehensive pooled analysis","volume":"20","author":"Eichenfield","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaci.2023.08.024_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003547","article-title":"Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia","volume":"9","author":"van Velzen","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaci.2023.08.024_bib22","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1128\/CVI.00123-08","article-title":"Gender-dependent HLA-DR\u2013restricted epitopes identified from herpes simplex virus type 1 glycoprotein D","volume":"15","author":"Zhang","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jaci.2023.08.024_bib23","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/cyto.a.20594","article-title":"Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities","volume":"73","author":"W\u00f6lfl","year":"2008","journal-title":"Cytometry A"},{"key":"10.1016\/j.jaci.2023.08.024_bib24","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.4049\/jimmunol.166.7.4578","article-title":"Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2","volume":"166","author":"Lindgren","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2023.08.024_bib25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm1292","article-title":"Direct access to CD4+ T cells specific for defined antigens according to CD154 expression","volume":"11","author":"Frentsch","year":"2005","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jaci.2023.08.024_bib26","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/jid.2015.162","article-title":"Der p 1 and Der p 2\u2013specific T cells display a Th2, Th17, and Th2\/Th17 phenotype in atopic dermatitis","volume":"135","author":"Roesner","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.08.024_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaci.2008.10.012","article-title":"Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice","volume":"123","author":"Dakhama","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.08.024_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2023.08.024_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/all.13685","article-title":"Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis","volume":"74","author":"Jonstam","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2023.08.024_bib30","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jid.2021.01.022","article-title":"Early and long-term effects of dupilumab treatment on circulating T-cell functions in patients with moderate-to-severe atopic dermatitis","volume":"141","author":"Bakker","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.08.024_bib31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaci.2011.02.014","article-title":"Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis","volume":"128","author":"de Benedetto","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.08.024_bib32","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1128\/JVI.76.14.7203-7208.2002","article-title":"Disruption of adherens junctions liberates nectin-1 to serve as receptor for herpes simplex virus and pseudorabies virus entry","volume":"76","author":"Yoon","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2023.08.024_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.08.024_bib34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2133.2010.09892.x","article-title":"History of eczema herpeticum is associated with the inability to induce human \u03b2-defensin (HBD)-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis","volume":"163","author":"Hata","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.08.024_bib35","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jid.2019.09.029","article-title":"RNase 7 promotes sensing of self-DNA by human keratinocytes and activates an antiviral immune response","volume":"140","author":"Kopfnagel","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.08.024_bib36","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jaci.2005.12.1345","article-title":"Cathelicidin deficiency predisposes to eczema herpeticum","volume":"117","author":"Howell","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.08.024_bib37","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/all.14664","article-title":"Dupilumab reduces inflammation and restores the skin barrier in patients with atopic dermatitis","volume":"76","author":"Rohner","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2023.08.024_bib38","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1093\/rheumatology\/keaa568","article-title":"Regulation of entheseal IL-23 expression by IL-4 and IL-13 as an explanation for arthropathy development under dupilumab therapy","volume":"60","author":"Bridgewood","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaci.2023.08.024_bib39","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.jid.2022.03.013","article-title":"T helper 2 IL-4\/IL-13 dual blockade with dupilumab is linked to some emergent T helper 17\u2012type diseases, including seronegative arthritis and enthesitis\/enthesopathy, but not to humoral autoimmune diseases","volume":"142","author":"Bridgewood","year":"2022","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923011065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923011065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:44:37Z","timestamp":1758793477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674923011065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0091674923011065"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2023.08.024","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dupilumab strengthens herpes simplex virus type 1\u2013specific immune responses in atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}